FDA

U.S. Food and Drug Administration Approves ABILIFY® (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)

Business Wire (Free subscription) | yesterday

PRINCETON, N.J. & TOKYO--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms...

Covidien says FDA extends Exalgo review

Seattle Times (Free subscription) | yesterday

Health care company Covidien PLC said Friday the Food and Drug Administration will take longer than expected to review the potential opioid pain drug Exalgo.

Dendreon says FDA will disclose Provenge’s fate by May 1

The Puget Sound Business Journal (Free subscription) | yesterday

Dendreon Corp. said the U.S. Food and Drug Administration said it will make a regulatory decision on the biotech’s Provenge prostate cancer drug by May 1, 2010. (DNDN)

American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products

Red Orbit (Free subscription) | yesterday

CHICAGO, Nov. 20 /PRNewswire-USNewswire/ -- The American Dental Association (ADA) today asked the U.S. Food and Drug Administration (FDA) to establish appropriate classifications for tooth-whitening chemicals.

Covidien says FDA extends Exalgo review

Seattle Post-Intelligencer (Free subscription) | yesterday

NEW YORK -- Health care company Covidien PLC said Friday the Food and Drug Administration will take longer than expected to review the potential opioid pain drug Exalgo.

Dendreon's Provenge gets FDA review date

Seattle Times (Free subscription) | yesterday

Biotechnology company Dendreon Corp. said Friday the Food and Drug Administration will make a regulatory decision on the potential prostate cancer vaccine Provenge by May 1.

Dendreon's Provenge gets FDA review date

Seattle Post-Intelligencer (Free subscription) | yesterday

SEATTLE -- Biotechnology company Dendreon Corp. said Friday the Food and Drug Administration will make a regulatory decision on the potential prostate cancer vaccine Provenge by May 1.

FDA Issues Warnings to Web Sites Over Drug Sales

ABC News (Free subscription) | 11/19/2009

FDA issues warning letters to 22 Web sites, alleges illegal sales of medical products Food and Drug Administration - Website - Health - Drugs - United States

• FDA issues warning letters to 22 Web sites, alleges illegal sales of medical products - Star Tribune
• FDA targets rogue Internet pharmacies - Security Fix
• See the 9 articles on the same subject

American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products

News Unfiltered (Free subscription) | yesterday

The American Dental Association (ADA) today asked the U.S. Food and Drug Administration (FDA) to establish appropriate classifications for tooth-whitening chemicals. Citing concern about the safety of whitening products that are often administered without the benefit of professional consultation or examination by a dentist, the Association said that the application of chemically based tooth whitening...

Advanced Cell Technology Files IND With FDA For First Human Clinical Trial Using Embryonic Stem Cells to Treat Eye Disease

Advanced Cell Technology (Free subscription) | 2 hours ago

WORCESTER, MA –November 19, 2009 (BUSINESS WIRE). Advanced Cell Technology, Inc. (OTCBB: ACTC – News announced today that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt’s Macular Dystrophy (SMD). Among the...

Advanced Cell Technology Files IND With FDA For First Human Clinical Trial Using Embryonic Stem Cells To Treat Eye Disease

Medical News Today (Free subscription) | 6 hours ago

Advanced Cell Technology, Inc. (OTCBB:ACTC) announced that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD). Among the most common causes of untreatable blindness in the world are degenerative diseases...

Pfizer Receives FDA Approval For Geodon® (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults

Business Wire (Free subscription) | yesterday

NEW YORK--(BUSINESS WIRE)--Pfizer today announced that the U.S. Food and Drug Administration (FDA) has approved Geodon® (ziprasidone HCI) Capsules for maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate in adults. The approval is based on clinical data demonstrating that Geodon is an effective and generally well-tolerated adjunctive treatment for long-term symptom...

Dendreon Receives FDA Acknowledgement of Complete Response

The Earth Times Online Newspaper (Free subscription) | yesterday

SEATTLE, Nov. 20 -- Dendreon Corporation (Nasdaq: DNDN) today announced that the U.S. Food and Drug Administration (FDA) provided written acknowledgement that the Company's amended Biologics License Application (BLA) for PROVENGE® (sipuleucel-T) is a complete...

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

The Earth Times Online Newspaper (Free subscription) | yesterday

NATICK, Mass. and LONDON, Nov. 20 -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex® Fully Covered Esophageal Stent for t...

FDA Approves Intravenous Formulation Of Pfizer’s Revatio® (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension

The Earth Times Online Newspaper (Free subscription) | yesterday

NEW YORK - Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved Revatio® (sildenafil) Injection, an intravenous formulation of Revatio. Revatio is the only FDA-approved phosphodiesterase-5 (PDE5) inhibitor available in both tablet and int

colonic hydrotherapy

jhon8125 | 11/16/2009

http://www.colonichydrotherapy.net There are so many ways of burning fat but do you know what’s the healthiest and easiest way how? A fast and easy way to lose fat is through colon cleansing. Colon cleansing is the removal of fecal wastes and unidentified toxins from the colon and intestinal tract. A form of colon cleansing is colonic hydrotherapy which is supposed to remove toxins in the body. However...

Get Relief from Chronic Pain - Buy Tramadol Online at OnlineTramadol.ws

backpainmedication | 11/08/2009

We've heard about all the great benefits when buy tramadol online: best prices, fast FedEx delivery the following day, and easy-prescription approval (if any at all). But with this great convenience is some risk of a possible disaster and catastrophe. So how do we avoid these risks, yet keep the benefits associated with online pharmacies? Quality pain reliever - tramadol online Since there are many...

Xenical over the counter diet pill, Diet pill that you can believe

jwilliam.j123 | 10/27/2009

Excess weight is a concern of health shared by many of us, but few are able to get rid of him. Xenical, which works on the principle of blocking the suction of some fat in the body helping to find an effective solution for your health problems. Used as a treatment for obesity and weight maintenance benefits, including a low fat diet and regular exercise regime. The creation of Roche is available by...